Key result
Acupuncture added to conventional therapy improves quality of life by ~3 points in AECOPD.
Why the study?
The effect of acupuncture as adjunctive therapy for acute exacerbation of chronic obstructive pulmonary disease was controversial.
Does acupuncture plus conventional western medicine improve clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease?
Meta-Analysis (n=915)
Does acupuncture plus conventional western medicine improve clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease?
Acupuncture as an adjunctive therapy may improve quality of life and blood gas parameters in patients with acute exacerbation of COPD, though the overall quality of evidence is limited.
Answers are grounded in this paper and cite their sources.
Supports adjunctive acupuncture for QoL and ABG in AECOPD; extends RCT meta-analysis but evidence quality limited.
Purpose: The effect of acupuncture as adjunctive therapy for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) was controversial. Thus, we aimed to evaluate the effects of acupuncture for treating AECOPD. Methods: Eight databases were searched from database inception to July 30, 2023. All RCTs compared acupuncture plus conventional western medicine with conventional western medicine alone were included. Outcomes were quality of life, lung function, blood oxygen condition, exercise capacity, daily symptoms, duration of hospitalization, and adverse events. The statistical analyses were conducted using Stata 17.0, and methodological quality was measured by the Cochrane bias risk assessment tool. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to assess the quality of evidence. Results: Twelve studies including 915 patients were included. Compared with conventional western medicine alone, acupuncture combined with conventional western therapy significantly improved quality of life (CAT: MD: − 3.25; 95% CI: − 3.73 to − 2.78, P < 0.001) and arterial blood gas (PaCO 2 : MD: − 1.85; 95% CI: − 2.74 to − 0.95, P < 0.001; PaO 2 : MD: 5.15; 95% CI: 1.22 to 9.07, P = 0.01). And for lung function, statistical benefits were found in FEV 1 /FVC (MD: 4.66; 95% CI: 2.21 to 7.12, P < 0.001), but no difference was seen for FEV 1 % (MD: 1.83; 95% CI: − 0.17 to 3.83, P = 0.073). There was no significant improvement in exercise capacity (6MWD: MD: 96.69; 95% CI: − 0.60 to 193.98, P = 0.051), hospitalization duration (MD: − 5.70; 95% CI: − 11.97 to 0.58, P = 0.075), and dyspnea (mMRC: MD: − 0.19; 95% CI: − 0.61 to 0.63, P = 0.376) between two groups. Overall bias for CAT and mMRC was in “high” risk, FEV1%, FEV 1 /FVC, PaCO 2 , and PaO 2 was in “some concern” and 1 RCT assessing hospitalization duration was in “low” risk. And the overall assessments were either moderate, low or very low certainty. Seven trials performed safety assessment of acupuncture, and no serious adverse events were reported. Conclusion: Acupuncture might have auxiliary effects on AECOPD. However, the quality of the evidence is limited, and more high-quality RCTs are needed to be performed in the future.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) conducted a meta-analysis in Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (n=915). Acupuncture plus conventional western medicine vs. Conventional western medicine alone was evaluated on Quality of life (CAT) (MD -3.25, 95% CI -3.73 to -2.78, p=<0.001). Acupuncture combined with conventional western therapy improved quality of life compared to conventional therapy alone in AECOPD.
Synapse has enriched 10 related papers. Consider them for comparative context: